Investor Presentation First Nine Months of 2023

124 Investor presentation First nine months of 2023 Diabetes market share and market growth in Region China Diabetes market growth and Novo Nordisk market share 40% 30% 20% DKK billion 40% 32% 20% Diabetes market size and growth ~-12% 28 0 -1 -3 Region China 25 25 0% ~-14% 10% -12% 33% 32% -14% 0% -20% Aug -NN market share Aug Aug NN Company A Others Aug 2020 -Market growth (right axis). -NN growth (right axis) 2023 2022 2023 Novo Nordisk Competitors Source: IQVIA, Aug 2023, Value, MAT; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. NN: Novo Nordisk Region China covers Mainland China, Taiwan, and Hong Kong; Market values are based on the list prices

View entire presentation